Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 17, 2017 - Issue 10
Submit an article Journal homepage
923
Views
17
CrossRef citations to date
0
Altmetric
Drug Evaluation

Anti-EGFR monoclonal antibody panitumumab for the treatment of patients with metastatic colorectal cancer: an overview of current practice and future perspectives

Francesca BattaglinClinical and Experimental Oncology Department, Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padova, ItalyView further author information
,
Vincenzo DadduzioClinical and Experimental Oncology Department, Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padova, ItalyView further author information
,
Francesca BergamoClinical and Experimental Oncology Department, Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padova, ItalyView further author information
,
Chiara ManaiClinical and Experimental Oncology Department, Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padova, ItalyView further author information
,
Marta SchirripaClinical and Experimental Oncology Department, Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padova, ItalyView further author information
,
Sara LonardiClinical and Experimental Oncology Department, Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padova, ItalyView further author information
,
Vittorina ZagonelClinical and Experimental Oncology Department, Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padova, ItalyView further author information
&
Fotios LoupakisClinical and Experimental Oncology Department, Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padova, ItalyCorrespondence[email protected]
View further author information
 show all
Pages 1297-1308 | Received 20 Mar 2017, Accepted 14 Jul 2017, Published online: 28 Jul 2017

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xiaojun Liang & Jie Shen. (2020) Impact of KRAS mutation status on outcomes of metastatic colorectal cancer treated with anti-angiogenic agents: a meta-analysis. Journal of Chemotherapy 32:1, pages 41-48.
Read now

Articles from other publishers (16)

Monu Kumar Kashyap, Akash Ved, Rajiv Ratan Singh Yadav, Akhand Pratap Singh, Mahima Kushwaha & Karuna S. Shukla. (2023) The Cell Death and Signal Transduction Mechanisms in Colorectal Carcinogenesis: Recent Advances. Anti-Cancer Agents in Medicinal Chemistry 23:12, pages 1361-1375.
Crossref
Wahyuni WahyuniAjeng DiantiniMohammad GhozaliSahidin I. (2022) A Review of Current treatment for Triple-Negative Breast Cancer (TNBC). Research Journal of Pharmacy and Technology, pages 409-418.
Crossref
Mohammed A. Mansour, Valentina S. Caputo & Eiman Aleem. (2021) Highlights on selected growth factors and their receptors as promising anticancer drug targets. The International Journal of Biochemistry & Cell Biology 140, pages 106087.
Crossref
Guido Giordano, Pietro Parcesepe, Giuseppina Bruno, Annamaria Piscazzi, Vincenzo Lizzi, Andrea Remo, Massimo Pancione, Mario Rosario D’Andrea, Elena De Santis, Luigi Coppola, Michele Pietrafesa, Alberto Fersini, Antonio Ambrosi & Matteo Landriscina. (2021) Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era. International Journal of Molecular Sciences 22:14, pages 7717.
Crossref
Dong Wei, Zhang Yu, Yue Cheng, Huang Jiawei, Gao Jian, Gao Hua & Dong Guilan. (2021) Dysregulated miR-137 and its target EGFR contribute to the progression of pituitary adenomas. Molecular and Cellular Endocrinology 520, pages 111083.
Crossref
Daisuke Kamakura, Ryutaro Asano, Hiroki Kawai & Masahiro Yasunaga. (2020) Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation. Cancer Immunology, Immunotherapy 70:1, pages 177-188.
Crossref
Adam Hermawan, Herwandhani Putri & Rohmad Yudi Utomo. (2019) Comprehensive bioinformatics study reveals targets and molecular mechanism of hesperetin in overcoming breast cancer chemoresistance. Molecular Diversity 24:4, pages 933-947.
Crossref
Haoxing D. Jin & Nathan W. Blessing. (2020) Cicatricial ectropion and madarosis associated with panitumumab treatment of metastatic colorectal cancer. American Journal of Ophthalmology Case Reports 19, pages 100810.
Crossref
Khalid El Bairi, Csongor Lengyel, Antonio Marra & Said Afqir. 2020. Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing. Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing 29 71 .
Nicole Trier, Paul Hansen & Gunnar Houen. (2019) Peptides, Antibodies, Peptide Antibodies and More. International Journal of Molecular Sciences 20:24, pages 6289.
Crossref
Chiara Bazzichetto, Fabiana Conciatori, Italia Falcone, Francesco Cognetti, Michele Milella & Ludovica Ciuffreda. (2019) Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer. Journal of Oncology 2019, pages 1-12.
Crossref
Bao T. Le, Prithi Raguraman, Tamer R. Kosbar, Susan Fletcher, Steve D. Wilton & Rakesh N. Veedu. (2019) Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics. Molecular Therapy - Nucleic Acids 14, pages 142-157.
Crossref
Yuanyuan Fu, Chengheng Liao, Kai Cui, Xiao Liu & Wentong Fang. (2019) Antitumor pharmacotherapy of colorectal cancer in kidney transplant recipients. Therapeutic Advances in Medical Oncology 11, pages 175883591987619.
Crossref
D. A. Andreev, A. A. Zav'yalov, K. A. Kokushkin & M. V. Davydovskaya. (2018) The application of the modern target medications for the treatment of metastatic colorectal cancer. Dokazatel'naya gastroenterologiya 7:2, pages 21.
Crossref
L. V. K. S. Bhaskar & L. Saikrishna. 2018. Role of Tyrosine Kinases in Gastrointestinal Malignancies. Role of Tyrosine Kinases in Gastrointestinal Malignancies 191 224 .
Isabel Corraliza-Gorjón, Beatriz Somovilla-Crespo, Silvia Santamaria, Jose A. Garcia-Sanz & Leonor Kremer. (2017) New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness. Frontiers in Immunology 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.